BlackRock Health Sciences Trust $BME Shares Acquired by Consolidated Portfolio Review Corp

Consolidated Portfolio Review Corp grew its stake in BlackRock Health Sciences Trust (NYSE:BME) by 40.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 54,522 shares of the company’s stock after purchasing an additional 15,643 shares during the period. Consolidated Portfolio Review Corp’s holdings in BlackRock Health Sciences Trust were worth $2,030,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Legacy Wealth Managment LLC ID acquired a new position in BlackRock Health Sciences Trust during the second quarter worth $55,000. SOA Wealth Advisors LLC. raised its holdings in shares of BlackRock Health Sciences Trust by 20.3% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after acquiring an additional 469 shares during the period. Geneos Wealth Management Inc. boosted its position in shares of BlackRock Health Sciences Trust by 200.0% during the 2nd quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock valued at $179,000 after acquiring an additional 3,266 shares during the last quarter. Sage Investment Counsel LLC purchased a new stake in shares of BlackRock Health Sciences Trust in the third quarter valued at about $201,000. Finally, Truist Financial Corp purchased a new stake in shares of BlackRock Health Sciences Trust in the third quarter valued at about $205,000.

BlackRock Health Sciences Trust Stock Down 2.4%

Shares of BME stock opened at $41.19 on Friday. The firm’s 50-day moving average is $41.88 and its two-hundred day moving average is $39.68. BlackRock Health Sciences Trust has a 12 month low of $34.18 and a 12 month high of $42.74.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 15th will be issued a $0.2621 dividend. The ex-dividend date is Monday, June 15th. This represents a c) dividend on an annualized basis and a yield of 7.6%.

BlackRock Health Sciences Trust Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.